Silva Pharmaceuticals Limited (DSE:SILVAPHL)
11.70
-0.20 (-1.68%)
At close: Aug 14, 2025
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 1.60 billion as of August 15, 2025. Its market cap has decreased by -24.52% in one year.
Market Cap
1.60B
Enterprise Value
1.50B
Revenue
431.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.70
Market Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 1.60B, a decrease of -57.64%. That is a compound annual growth rate of -11.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 1.60B | 14.71% |
Dec 30, 2024 | 1.39B | -52.78% |
Dec 28, 2023 | 2.95B | - |
Dec 29, 2022 | 2.95B | 20.67% |
Dec 30, 2021 | 2.44B | -2.19% |
Dec 30, 2020 | 2.50B | 8.93% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grameenphone | 425.75B |
Square Pharmaceuticals PLC. | 199.72B |
British American Tobacco Bangladesh Company | 156.92B |
Robi Axiata PLC. | 140.38B |
BRAC Bank PLC. | 136.38B |
Walton Hi-Tech Industries | 135.14B |
Bangladesh Export Import Company | 103.85B |
Marico Bangladesh | 90.91B |